Strength
37.5 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342019407
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
4/23/2025
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204889On Market Since
10/6/2017
Pharmacological Classes
Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor
Related Drugs
Same classification
CITALOPRAM HBR 10 MG TABLET
Generic
00378623101•Mylan Pharmaceuticals Inc.
$0.0254
per EA
CITALOPRAM HBR 10 MG TABLET
Generic
00378623105•Mylan Pharmaceuticals Inc.
$0.0254
per EA
CITALOPRAM HBR 10 MG TABLET
Generic
00904608461•Major Pharmaceuticals
$0.0254
per EA
CITALOPRAM HBR 10 MG TABLET
Generic
13668000901•Torrent Pharmaceuticals Limited
$0.0254
per EA
CITALOPRAM HBR 10 MG TABLET
Generic
13668000905•Torrent Pharmaceuticals Limited
$0.0254
per EA
CITALOPRAM HBR 10 MG TABLET
Generic
13668000909•Torrent Pharmaceuticals Limited
$0.0254
per EA
CITALOPRAM HBR 10 MG TABLET
Generic
42806001901•Epic Pharma LLC
$0.0254
per EA
CITALOPRAM HBR 10 MG TABLET
Generic
42806001910•Epic Pharma LLC
$0.0254
per EA
CITALOPRAM HBR 10 MG TABLET
Generic
65862000501•Aurobindo Pharma Limited
$0.0254
per EA
CITALOPRAM HBR 10 MG TABLET
Generic
65862000505•Aurobindo Pharma Limited
$0.0254
per EA